MedPath
HSA Approval

LACTORIDE 500 INFUSION

SIN09647P

LACTORIDE 500 INFUSION

LACTORIDE 500 INFUSION

February 18, 1998

PHARMATECH MEDICAL ENTERPRISE PTE LTD

PHARMATECH MEDICAL ENTERPRISE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMATECH MEDICAL ENTERPRISE PTE LTD
Licence HolderPHARMATECH MEDICAL ENTERPRISE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

A02AX

治酸药, 其它复方

Manufacturer Information

PHARMATECH MEDICAL ENTERPRISE PTE. LTD.

BEXIMCO PHARMACEUTICALS LTD

Active Ingredients

CALCIUM CHLORIDE

0.027% w/v

Calcium chloride

SODIUM CHLORIDE

0.6% w/v

Sodium chloride

SODIUM LACTATE

0.32% w/v

Lactic acid

POTASSIUM CHLORIDE

0.04% w/v

Potassium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LACTORIDE 500 INFUSION - HSA Approval | MedPath